ADMA
ADMA Biologics·NASDAQ
--
--(--)
--
--(--)
ADMA fundamentals
ADMA Biologics (ADMA) Revenue Breakdown: Q3 2025 Business & Regional Performance
ADMA Biologics (ADMA) reported total revenue of 134.22M USD in Q3 2025, with its core business segment ADMA Biomanufacturing contributing 99.97%. Regionally, United States remained the largest market, accounting for 99.82% of total revenue. Explore ADMA Biologics's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
ADMA Biologics (ADMA) reported total revenue of 134.22M USD in Q3 2025, with its core business segment ADMA Biomanufacturing contributing 99.97%. Regionally, United States remained the largest market, accounting for 99.82% of total revenue. Explore ADMA Biologics's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What guidance did ADMA Biologics's management provide for the next earnings period?What were the key takeaways from ADMA Biologics’s earnings call?What factors drove the changes in ADMA Biologics's revenue and profit?What is ADMA Biologics's gross profit margin?What were the key takeaways from ADMA Biologics's earnings call?Did ADMA Biologics beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for ADMA Biologics year over year?What is the market's earnings forecast for ADMA Biologics next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
